Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: PharmacoEconomics - Open, Vol. 1, No. 2, 06.2017, p. 99-108.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process
AU - Kaltenthaler, Eva
AU - Carroll, Christopher
AU - Hill-McManus, Daniel
AU - Scope, Alison
AU - Holmes, Michael
AU - Rice, Stephen
AU - Rose, Micah
AU - Tappenden, Paul
AU - Woolacott, Nerys
PY - 2017/6
Y1 - 2017/6
N2 - Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critique of the evidence submitted by companies, the ERGs undertake exploratory analyses to explore uncertainties in the company's model. The aim of this study was to explore pre-defined factors that might influence or predict the extent of ERG exploratory analyses.
AB - Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critique of the evidence submitted by companies, the ERGs undertake exploratory analyses to explore uncertainties in the company's model. The aim of this study was to explore pre-defined factors that might influence or predict the extent of ERG exploratory analyses.
U2 - 10.1007/s41669-016-0001-4
DO - 10.1007/s41669-016-0001-4
M3 - Article
VL - 1
SP - 99
EP - 108
JO - PharmacoEconomics - Open
JF - PharmacoEconomics - Open
SN - 2509-4254
IS - 2
ER -